These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20603031)

  • 41. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.
    Lip GY; Huber K; Andreotti F; Arnesen H; Airaksinen KJ; Cuisset T; Kirchhof P; Marín F;
    Thromb Haemost; 2010 Jan; 103(1):13-28. PubMed ID: 20062939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of cardiac surgery on hemostasis.
    Hartmann M; Sucker C; Boehm O; Koch A; Loer S; Zacharowski K
    Transfus Med Rev; 2006 Jul; 20(3):230-41. PubMed ID: 16787830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes.
    De Carlo M; Borelli G; Gistri R; Ciabatti N; Mazzoni A; Arena M; Petronio AS
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):408-15. PubMed ID: 19360863
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Bleeding risk and acute coronary syndromes in the elderly].
    Bounhoure JP; Montastruc JL
    Bull Acad Natl Med; 2011 Nov; 195(8):1981-7. PubMed ID: 22844755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
    White HD; Kleiman NS; Mahaffey KW; Lokhnygina Y; Pieper KS; Chiswell K; Cohen M; Harrington RA; Chew DP; Petersen JL; Berdan LG; Aylward PE; Nessel CC; Ferguson JJ; Califf RM
    Am Heart J; 2006 Dec; 152(6):1042-50. PubMed ID: 17161049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coagulopathy management in liver transplantation.
    Sabate A; Dalmau A; Koo M; Aparicio I; Costa M; Contreras L
    Transplant Proc; 2012; 44(6):1523-5. PubMed ID: 22841202
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.
    Chew DP; Huang Z; Pieper KS; White H; Mahaffey KW; Ferguson JJ; Califf RM; Aylward PG
    Am Heart J; 2008 Feb; 155(2):239-44. PubMed ID: 18215592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The medical management of acute coronary syndromes and potential roles for new antithrombotic agents.
    Pollack CV; Goldberg AD
    J Emerg Med; 2008 May; 34(4):417-28. PubMed ID: 18226874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Bleeding risk in ST-segment elevation myocardial infarction].
    Benamer H; Meftout B; Chevalier B
    Ann Cardiol Angeiol (Paris); 2010 Dec; 59(6):356-61. PubMed ID: 21056406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fibrinolytic therapy and bleeding complications: risk predictors from RIKS-HIA.
    Oldgren J; Wernroth L; Stenestrand U;
    Heart; 2010 Sep; 96(18):1451-7. PubMed ID: 20657008
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of massive operative blood loss.
    Kozek-Langenecker S
    Minerva Anestesiol; 2007; 73(7-8):401-15. PubMed ID: 17380100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of surgical hemostasis: systemic agents.
    Levy JH; Tanaka KA
    Vascular; 2008; 16 Suppl 1():S14-21. PubMed ID: 18544301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of antithrombotic therapy for acute coronary syndromes and atrial fibrillation in patients with hemophilia.
    Mannucci PM
    Expert Opin Pharmacother; 2012 Mar; 13(4):505-10. PubMed ID: 22332913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coagulopathy in liver disease: a balancing act.
    Kujovich JL
    Hematology Am Soc Hematol Educ Program; 2015; 2015():243-9. PubMed ID: 26637729
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of coagulation abnormalities in liver disease.
    Potze W; Porte RJ; Lisman T
    Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):103-14. PubMed ID: 24970667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Disorders of hemostasis in chronic renal failure and renal transplantation].
    Goluza E; Topalović MG; Hudolin T; Konosić S; Kocman IB; Perić M
    Acta Med Croatica; 2011; 65(4):337-47. PubMed ID: 22359906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing bleeding risk in acute coronary syndromes.
    Erdem G; Flather M
    Rev Esp Cardiol (Engl Ed); 2012 Jan; 65(1):4-6. PubMed ID: 22056593
    [No Abstract]   [Full Text] [Related]  

  • 58. [Bleeding risk related to combined aspirin and other antithrombotic drug use in patients with acute coronary syndrome: prevention and therapy strategies].
    Li XY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Dec; 38(12):1057-9. PubMed ID: 21215136
    [No Abstract]   [Full Text] [Related]  

  • 59. Management of acquired bleeding problems in cancer patients.
    DeLoughery TG
    Emerg Med Clin North Am; 2009 Aug; 27(3):423-44. PubMed ID: 19646646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surgery and hemostasis.
    Lawson JW; Kitchens CS
    Curr Opin Hematol; 2015 Sep; 22(5):420-7. PubMed ID: 26248002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.